Skip to content

Dexamethasone alone or in combination with acupoints compatibility in prevention of postoperative nausea and vomiting after gynecological laparoscopic surgery: a randomized controlled trial

Dexamethasone alone or in combination with acupoints compatibility in prevention of postoperative nausea and vomiting after gynecological laparoscopic surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022090
Enrollment
Unknown
Registered
2019-03-24
Start date
2019-04-08
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting

Interventions

dexamethasone group:examethasone
Dexamethasone combined with neiguan acupoint group:Dexamethasone combined with neiguan acupoint
Dexamethasone combined with neiguan, zusanli and hegu acupoints group:Dexamethasone combined with neiguan, zusanli and hegu acupoints

Sponsors

Tianjin Nankai Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-64 years; (2) ASA I~II?; (3) Body mass index (bmi) 18~30kg/m2; (4) Signing the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with serious heart, lung, brain and other important organ diseases who need complex comprehensive monitoring and treatment; (2) Patients with poor physical conditions who cannot tolerate anesthesia; (3) Those who are allergic to the narcotic drugs needed; (4) Those who have received electroacupuncture stimulation therapy; (5) Contraindication of percutaneous acupoint electrical stimulation, including skin damage, infection at the site of injection or electrophysiological devices in the body Implant; (6) Fear of needles; (7) Has a history of mental illness.

Design outcomes

Primary

MeasureTime frame
Postoperative nausea and vomiting;Patient satisfaction;

Countries

China

Contacts

Public ContactJianbo Yu
jianboyu99@sina.com+86 18698087176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026